Literature DB >> 15456407

Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.

Nicole R Bianco1, Laura J Chaplin, Monica M Montano.   

Abstract

Quinone reductase (QR) is a phase II detoxification enzyme that plays an important role in detoxifying quinones and may help maintain the antioxidant function of the cell. We have previously observed that QR is up-regulated by anti-oestrogens, but not oestrogen, in breast cancer cells via ERbeta (oestrogen receptor beta) transactivation. Such QR induction appears to protect breast cells against oestrogen-induced oxidative DNA damage, most likely by reducing reactive oestrogen metabolites termed catecholestrogen-quinones back to the hydroxy-catecholestrogens which may be conjugated. We now report that the phytoestrogens biochanin A, genistein and resveratrol also up-regulate QR expression in breast cancer cells. We observe that regulation can occur at the transcriptional level, preferentially through ERbeta transactivation at the electrophile response element of the QR gene promoter. By chromatin immunoprecipitation analysis, we show binding of ERalpha and ERbeta to the QR promoter, with increased ERbeta binding in the presence of resveratrol. Functional studies show that biochanin A and resveratrol, but not genistein, can significantly protect against oestrogen-induced oxidative DNA damage in breast cancer cells. Antisense technology was used to determine whether such protection was dependent on ERbeta or QR. Our results with resveratrol are consistent with our hypothesis that the protective ability of resveratrol is partially dependent on the presence of ERbeta and QR. In conclusion, we postulate that phytoestrogen-mediated induction of QR may represent an additional mechanism for breast cancer protection, although the effects may be specific for a given phytoestrogen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15456407      PMCID: PMC1134696          DOI: 10.1042/BJ20040959

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Induction of NQO1 in cancer cells.

Authors:  Asher Begleiter; Jeanne Fourie
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.

Authors:  M M Montano; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

3.  Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.

Authors:  Nicole R Bianco; George Perry; Mark A Smith; Dennis J Templeton; Monica M Montano
Journal:  Mol Endocrinol       Date:  2003-04-24

4.  Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.

Authors:  M M Montano; K Ekena; K D Krueger; A L Keller; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1996-03

5.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence.

Authors:  Paul Nioi; Michael McMahon; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

6.  Enhancement of lung carcinogenesis by nonylphenol and genistein in a F344 rat multiorgan carcinogenesis model.

Authors:  Noritaka Seike; Hideki Wanibuchi; Keiichirou Morimura; Min Wei; Takayuki Nishikawa; Kazuto Hirata; Junichi Yoshikawa; Shoji Fukushima
Journal:  Cancer Lett       Date:  2003-03-20       Impact factor: 8.679

7.  Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray.

Authors:  Sang Hwa Yang; Jong Sik Kim; Tae Jeong Oh; Myung Soon Kim; Sun Woo Lee; Suk Kyung Woo; Hyun Sill Cho; Yung Hyun Choi; Young Ho Kim; Sun Young Rha; Hyun Cheol Chung; Sung Whan An
Journal:  Int J Oncol       Date:  2003-04       Impact factor: 5.650

8.  Critical role of oxidative stress in estrogen-induced carcinogenesis.

Authors:  Hari K Bhat; Gloria Calaf; Tom K Hei; Theresa Loya; Jaydutt V Vadgama
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

Review 9.  Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.

Authors:  Pamela J Magee; Ian R Rowland
Journal:  Br J Nutr       Date:  2004-04       Impact factor: 3.718

Review 10.  Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action.

Authors:  Tomas Barkhem; Stefan Nilsson; Jan-Ake Gustafsson
Journal:  Am J Pharmacogenomics       Date:  2004
View more
  14 in total

1.  DNA sequence determinants of nuclear protein binding to the c-Ha-ras antioxidant/electrophile response element in vascular smooth muscle cells: identification of Nrf2 and heat shock protein 90 beta as heterocomplex components.

Authors:  Kimberly P Miller; Kenneth S Ramos
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

2.  The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Liping Wang; Xiaoqing He; Grazyna D Szklarz; Yongyi Bi; Yon Rojanasakul; Qiang Ma
Journal:  Arch Biochem Biophys       Date:  2013-06-22       Impact factor: 4.013

3.  Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis.

Authors:  Nirmala Krishnamurthy; Yanduan Hu; Sandra Siedlak; Yong Qiu Doughman; Michiko Watanabe; Monica M Montano
Journal:  FASEB J       Date:  2012-06-14       Impact factor: 5.191

4.  Chemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease prevention.

Authors:  Aimee L Eggler; Sergey N Savinov
Journal:  Recent Adv Phytochem       Date:  2013-12-03

Review 5.  Estrogen receptor-beta and breast cancer: translating biology into clinical practice.

Authors:  Yuet-Kin Leung; Ming-Tsung Lee; Hung-Ming Lam; Pheruza Tarapore; Shuk-Mei Ho
Journal:  Steroids       Date:  2012-03-29       Impact factor: 2.668

6.  Biochanin A inhibits breast cancer tumor growth in a murine xenograft model.

Authors:  Young Jin Moon; Beom Soo Shin; Guohua An; Marilyn E Morris
Journal:  Pharm Res       Date:  2008-05-03       Impact factor: 4.200

7.  Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.

Authors:  Nilesh W Gaikwad; Li Yang; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2008-11-01       Impact factor: 7.376

8.  Induction of metallothionein I by arsenic via metal-activated transcription factor 1: critical role of C-terminal cysteine residues in arsenic sensing.

Authors:  Xiaoqing He; Qiang Ma
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

9.  Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones.

Authors:  Nilesh W Gaikwad; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2007-08-03       Impact factor: 7.376

Review 10.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.